Most linked-to pages
From GxPlex
Showing below up to 50 results in range #1,451 to #1,500.
- Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (o) (4 links)
- Reference:USA 21 CFR Part 50 09-Apr-2025 § 50.3 (s) (4 links)
- Reference:USA 21 CFR Part 56 09-Apr-2025 - (4 links)
- Reference:USA 21 CFR Part 56 09-Apr-2025 Subpart B (4 links)
- Reference:USA 21 CFR Part 56 09-Apr-2025 § 56.111 - §56.112 (4 links)
- Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.64 (4 links)
- Reference:USA 42 CFR Part 11 09-Apr-2025 § 11.8 (4 links)
- Reference:USA 45 CFR Part 46 09-Apr-2025 § 46.102 (m) (4 links)
- Reference:USA 45 CFR Part 46 09-Apr-2025 § 46.104 (4 links)
- Reference:USA 45 CFR Part 46 09-Apr-2025 § 46.123 (4 links)
- Reference:USA 45 CFR Part 46 09-Apr-2025 § 46.124 (4 links)
- Reference:USA FD&C Act - Federal Food, Drug, and Cosmetic Act 30-Sep-2023 Section 513 (4 links)
- Reference:USA FDA - E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1): Guidance for Industry March 2018 - (4 links)
- Reference:USA NIH - Glossary 27-May-2025 Observational study (4 links)
- Reference:USA Recognized Consensus Standards - ISO 14155 21-Dec-2020 - (4 links)
- Reference:USA U.S. Code Title 21 30-Sep-2023 § 321 (f) (4 links)
- Reference:USA U.S. Code Title 21 30-Sep-2023 § 321 (i) (4 links)
- Reference:WHO WHO - Guidance for best practices for clinical trials 2024 1.1 - Clinical Research (4 links)
- Reference:WHO WHO - Guidance for best practices for clinical trials 2024 1.1 - NIS (4 links)
- Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.1 (4 links)
- Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 5 (4 links)
- Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - escape treatment (4 links)
- Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - investigator’s brochure (4 links)
- Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 Glossary - pharmaceutical product (4 links)
- Glossary:TAG-00004-Ser-ege (4 links)
- Glossary:TAG-00007-Cli-lin (4 links)
- Glossary:TAG-00009-Low-gra (4 links)
- Glossary:TAG-00014-Aux-kat (4 links)
- Glossary:TAG-00036-Sta-ung (4 links)
- Glossary:TAG-00047-Une-ete (4 links)
- Glossary:TAG-00061-Cli-rtr (4 links)
- Glossary:TAG-00088-Clo-esu (4 links)
- Glossary:TAG-00099-Ran-ndl (4 links)
- Glossary:TAG-00104-Bio-sch (4 links)
- Glossary:TAG-00153-Tri-nsc (4 links)
- Glossary:TAG-00175-Per-ist (4 links)
- Glossary:TAG-00209-Pos-sch (4 links)
- Glossary:TAG-00235-Int-stu (4 links)
- Glossary:TAG-00268-Wit-DIN (4 links)
- Glossary:TAG-00289-Ris-Qua (4 links)
- Glossary:TAG-00291-Qua-tsk (4 links)
- Glossary:TAG-00305-Sta-Sta (4 links)
- Glossary:TAG-00326-Fed-wes (4 links)
- Glossary:TAG-00344-Art-ngK (4 links)
- About GxPlex (3 links)
- MediaWiki:Smw import foaf (3 links)
- Document:AUT Ärztegesetz 08-Mar-2023 (3 links)
- Document:CIOMS CIOMS - International Ethical Guidelines for Health-related Research Involving Humans 2016 (3 links)
- Document:DEU TAMG - Tierarzneimittelgesetz 14-Mar-2024 (3 links)
- Document:EUR European Bioethics Convention 1997 (3 links)